Literature DB >> 36244344

Omicron-adapted vaccines might require longer follow-up to reveal true benefits.

Lu Tang1, Ruihua Zhang2, Miao Cui3, Peng Hong4.   

Abstract

Entities:  

Year:  2022        PMID: 36244344      PMCID: PMC9560758          DOI: 10.1016/S2666-5247(22)00292-0

Source DB:  PubMed          Journal:  Lancet Microbe        ISSN: 2666-5247


× No keyword cloud information.
  10 in total

1.  Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection.

Authors:  Chengzi I Kaku; Alan J Bergeron; Clas Ahlm; Johan Normark; Mrunal Sakharkar; Mattias N E Forsell; Laura M Walker
Journal:  Sci Immunol       Date:  2022-07-29

2.  The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants.

Authors:  Marios Koutsakos; Wen Shi Lee; Arnold Reynaldi; Hyon-Xhi Tan; Grace Gare; Paul Kinsella; Kwee Chin Liew; George Taiaroa; Deborah A Williamson; Helen E Kent; Eva Stadler; Deborah Cromer; David S Khoury; Adam K Wheatley; Jennifer A Juno; Miles P Davenport; Stephen J Kent
Journal:  Immunity       Date:  2022-05-27       Impact factor: 43.474

3.  Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost.

Authors:  Frauke Muecksch; Zijun Wang; Alice Cho; Christian Gaebler; Tarek Ben Tanfous; Justin DaSilva; Eva Bednarski; Victor Ramos; Shuai Zong; Brianna Johnson; Raphael Raspe; Dennis Schaefer-Babajew; Irina Shimeliovich; Mridushi Daga; Kai-Hui Yao; Fabian Schmidt; Katrina G Millard; Martina Turroja; Mila Jankovic; Thiago Y Oliveira; Anna Gazumyan; Marina Caskey; Theodora Hatziioannou; Paul D Bieniasz; Michel C Nussenzweig
Journal:  Nature       Date:  2022-04-21       Impact factor: 69.504

4.  SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses.

Authors:  Alexandra C Walls; Kaitlin R Sprouse; John E Bowen; Anshu Joshi; Nicholas Franko; Mary Jane Navarro; Cameron Stewart; Elisabetta Cameroni; Matthew McCallum; Erin A Goecker; Emily J Degli-Angeli; Jenni Logue; Alex Greninger; Davide Corti; Helen Y Chu; David Veesler
Journal:  Cell       Date:  2022-01-20       Impact factor: 41.582

5.  A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2.

Authors:  Yaochang Yuan; Xiantao Zhang; Ran Chen; Yuzhuang Li; Bolin Wu; Rong Li; Fan Zou; Xiancai Ma; Xuemei Wang; Qier Chen; Jieyi Deng; Yongli Zhang; Tao Chen; Yingtong Lin; Shumei Yan; Xu Zhang; Congrong Li; Xiuqing Bu; Yi Peng; Changwen Ke; Kai Deng; Ting Pan; Xin He; Yiwen Zhang; Hui Zhang
Journal:  Cell Rep       Date:  2021-12-23       Impact factor: 9.423

6.  Affinity maturation for an optimal balance between long-term immune coverage and short-term resource constraints.

Authors:  Victor Chardès; Massimo Vergassola; Aleksandra M Walczak; Thierry Mora
Journal:  Proc Natl Acad Sci U S A       Date:  2022-02-22       Impact factor: 12.779

7.  Finite neutralisation breadth of omicron after repeated vaccination.

Authors:  Yufang Zhu; Yingying Lu; Lu Tang; Caili Zhou; Ran Liang; Miao Cui; Yunsheng Xu; Zhihua Zheng; Zhengjiang Cheng; Peng Hong
Journal:  Lancet Microbe       Date:  2022-07-21

8.  A Bivalent Omicron-Containing Booster Vaccine against Covid-19.

Authors:  Spyros Chalkias; Charles Harper; Keith Vrbicky; Stephen R Walsh; Brandon Essink; Adam Brosz; Nichole McGhee; Joanne E Tomassini; Xing Chen; Ying Chang; Andrea Sutherland; David C Montefiori; Bethany Girard; Darin K Edwards; Jing Feng; Honghong Zhou; Lindsey R Baden; Jacqueline M Miller; Rituparna Das
Journal:  N Engl J Med       Date:  2022-09-16       Impact factor: 176.079

9.  Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection.

Authors:  Zijun Wang; Frauke Muecksch; Dennis Schaefer-Babajew; Shlomo Finkin; Charlotte Viant; Christian Gaebler; Hans- Heinrich Hoffmann; Christopher O Barnes; Melissa Cipolla; Victor Ramos; Thiago Y Oliveira; Alice Cho; Fabian Schmidt; Justin Da Silva; Eva Bednarski; Lauren Aguado; Jim Yee; Mridushi Daga; Martina Turroja; Katrina G Millard; Mila Jankovic; Anna Gazumyan; Zhen Zhao; Charles M Rice; Paul D Bieniasz; Marina Caskey; Theodora Hatziioannou; Michel C Nussenzweig
Journal:  Nature       Date:  2021-06-14       Impact factor: 49.962

10.  Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations.

Authors:  Frauke Muecksch; Yiska Weisblum; Christopher O Barnes; Fabian Schmidt; Dennis Schaefer-Babajew; Zijun Wang; Julio C C Lorenzi; Andrew I Flyak; Andrew T DeLaitsch; Kathryn E Huey-Tubman; Shurong Hou; Celia A Schiffer; Christian Gaebler; Justin Da Silva; Daniel Poston; Shlomo Finkin; Alice Cho; Melissa Cipolla; Thiago Y Oliveira; Katrina G Millard; Victor Ramos; Anna Gazumyan; Magdalena Rutkowska; Marina Caskey; Michel C Nussenzweig; Pamela J Bjorkman; Theodora Hatziioannou; Paul D Bieniasz
Journal:  Immunity       Date:  2021-07-29       Impact factor: 31.745

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.